Clemens B. Caspar
Baden, AG, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
Journal: The Lancet. Haematology
Published: August 02, 2023
A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer.
Journal: Scientific reports
Published: October 04, 2022
Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14].
Journal: Journal of geriatric oncology
Published: February 02, 2022
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland.
Journal: Hematological oncology
Published: November 21, 2020
Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents- a real-world cross-sectional study from Switzerland (SAKK 95/16).
Journal: BMC cancer
Published: October 09, 2020
Patterns of care for patients with metastatic bone disease in solid tumors: A cross-sectional study from Switzerland (SAKK 95/16).
Journal: Journal of bone oncology
Published: November 01, 2019
Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burden.
Journal: Hematological oncology
Published: July 17, 2019
ALK-negative anaplastic large cell lymphoma arising in the thrombus of an aortic prosthesis preceeded by clonally related lymphomatoid papulosis.
Journal: Virchows Archiv : an international journal of pathology
Published: December 10, 2018
Quality of Life in Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer Using Cabazitaxel or Other Therapies After Previous Docetaxel Chemotherapy: Swiss Observational Treatment Registry.
Journal: Clinical genitourinary cancer
Published: June 08, 2017
Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08.
Journal: British journal of haematology
Published: October 13, 2015
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Journal: The Lancet. Oncology
Published: June 14, 2015
Last Updated: 09/26/2026